Related Experiment Videos
Association of undernutrition and tuberculosis outcomes: a retrospective multicentre cohort study in Italy
Francesco Di Gennaro1, Giacomo Guido1, Gina Gualano2
1Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy.
Objectives:
Undernutrition remains one of the most powerful yet neglected determinants of tuberculosis (TB) incidence and progression. Although its impact on TB outcomes has been extensively described in low-income countries, limited evidence is available from high-income settings. This study aimed to assess the association between body mass index (BMI) strata at treatment initiation and TB-related outcomes in a large multicentre cohort from Italy.
Methods:
We conducted a retrospective, multicentre observational study including all adults diagnosed with TB between January 2021 and August 2025 in 16 Infectious and Tropical Diseases Units across seven Italian regions. Patients were stratified by BMI at treatment initiation (<16, 16-16.99, 17-18.49, 18.5-24.99, and ≥25 kg/m2). Outcomes included time to sputum conversion, length of hospital stay, occurrence and severity of adverse events, incomplete treatment (including failure, death, and loss to follow-up), and loss to follow-up. Multilevel regression models adjusting for study centre and relevant confounders were used to assess associations between BMI strata and each outcome.
Results:
A total of 709 people with TB were included (median age, 38 years [interquartile range 28-53]; 488/709, 75.5% male). Overall, 299 of 709 (42%) were underweight (BMI <18.5 kg/m2). Compared with people with TB with normal BMI (18.5-24.99 kg/m2), those with severe undernutrition (BMI <16 kg/m2) showed higher rates of adverse events (54/74 [73.0%] vs. 101/410 [24.6%]; adjusted OR [aOR] 12.17, 95% CI 6.41-23.08), incomplete treatment (53/74 [71.6%] vs. 87/410 [21.2%]; aOR 18.28, 95% CI 6.70-49.80), and loss to follow-up (41/74 [55.4%] vs. 81/410 [19.7%]; aOR 5.99, 95% CI 2.58-13.90). Median hospital stay was also longer in this group (50 days [interquartile range 24-66] vs. 30 days [interquartile range 18-60]), corresponding to a 23% adjusted increase. Weight gain during the first 6 months of treatment was not significantly associated with major outcomes.
Conclusions:
Severe underweight at treatment initiation is a major independent predictor of poor outcomes in TB. These findings highlight the need for systematic nutritional assessment and targeted interventions within TB programmes, even in high-income, low-incidence settings.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...